Senior author Ann Marie Pendergast, Ph.D., and researchers from Duke Cancer Institute found a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

A new study comparing discharged COVID-19 hospital patients to discharged patients who were hospitalized for other reasons showed the COVID patients were 45% more likely to experience heart failure within a year following their discharge.

Duke-NUS Medical School has admitted 72 students to its 16th cohort of the MD program.

In this Op-ed, Camille Robinson, a fourth-year medical student, 2021-22 North Carolina Albert Schweitzer Fellow, and co-founder of the Black Maternal Health Equity Initiative at the School of Medicine, issues a call to action to address racial disparities.

The Duke Center for Brain and Spine Metastasis (DCBSM) has become one of the most comprehensive destination programs in the country for treating the growing population of patients whose cancer has spread to the brain, spine, and other parts of the central nervous system. 

The Division of Nuclear Medicine and Radiotheranostics at Duke Health has been named a Comprehensive Radiopharmaceutical Therapy Center of Excellence. Duke is one of only 14 centers in the U.S. to receive this recognition.

Five School of Medicine faculty were among the recipients of funding from the inaugural Duke Science and Technology (DST) Launch Seed Grant Program.

Study links lower test scores among Black North Carolina fourth graders to environmental exposure in racially segregated neighborhoods.

When the class of 2022 interviewed for their place in the Duke Physician Program there was no inkling of the pandemic that would change the shape of the world for years to come.

Duke University continues its investment in science faculty recruitment and retention with the selection of four additional Duke Science and Technology Scholars.